ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
Status PubMed-not-MEDLINE Language English Country Great Britain, England Media electronic-ecollection
Document type Review, Journal Article
Grant support
G0901530
Medical Research Council - United Kingdom
MR/J000388/1
Medical Research Council - United Kingdom
PubMed
28050247
PubMed Central
PMC5203711
DOI
10.1186/s13601-016-0137-4
PII: 137
Knihovny.cz E-resources
- Keywords
- AIRWAYS ICPs, ARIA, EIP on AHA, ICT, Mobile technology, Rhinitis,
- Publication type
- Journal Article MeSH
- Review MeSH
The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization workshop in 1999. The initial goals were (1) to propose a new allergic rhinitis classification, (2) to promote the concept of multi-morbidity in asthma and rhinitis and (3) to develop guidelines with all stakeholders that could be used globally for all countries and populations. ARIA-disseminated and implemented in over 70 countries globally-is now focusing on the implementation of emerging technologies for individualized and predictive medicine. MASK [MACVIA (Contre les Maladies Chroniques pour un Vieillissement Actif)-ARIA Sentinel NetworK] uses mobile technology to develop care pathways for the management of rhinitis and asthma by a multi-disciplinary group and by patients themselves. An app (Android and iOS) is available in 20 countries and 15 languages. It uses a visual analogue scale to assess symptom control and work productivity as well as a clinical decision support system. It is associated with an inter-operable tablet for physicians and other health care professionals. The scaling up strategy uses the recommendations of the European Innovation Partnership on Active and Healthy Ageing. The aim of the novel ARIA approach is to provide an active and healthy life to rhinitis sufferers, whatever their age, sex or socio-economic status, in order to reduce health and social inequalities incurred by the disease.
1st Department of Family Medicine Medical University of Lodz Lodz Poland
Academic Medical Centre University of Amsterdam Amsterdam The Netherlands
Allergy and Asthma Associates of Southern California Mission Viejo CA USA
Allergy and Asthma Medical Group and Research Center San Diego CA USA
Allergy and Clinical Immunology Department Hospital CUF Descobertas Lisbon Portugal
Allergy and Immunology Division Clinica Ricardo Palma Lima Peru
Allergy Unit Complesso Integrato Columbus Rome Italy
Allergy Unit Department of Dermatology University Hospital of Zurich Zurich Switzerland
AQuAS Barcelona Spain ; EUREGHA European Regional and Local Health Association Brussels Belgium
Association Asthme et Allergie Paris France
Asthma and Allergy Clinic Humanitas University Rozzano Milan Italy
Asthma UK Mansell Street London UK
Athens Chest Hospital Athens Greece
Barcelona Institute for Global Health Barcelona Spain
Biomax Informatics AG Munich Germany
Bradford Institute for Health Research Bradford Royal Infirmary Bradford UK
Caisse d'assurance retraite et de la santé au travail du Languedoc Roussillon Montpellier France
Cardio Thoracic and Vascular Department University Hospital of Pisa Pisa Italy
Center for Rhinology and Allergology Wiesbaden Germany
Center of Tuberculosis and Lung Diseases Latvian Association of Allergists Riga Latvia
Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle Ouagadougou Burkina Faso
Centre of Pneumology Coimbra University Hospital Coimbra Portugal
Centre of Pneumology Faculty of Medicine University of Coimbra Coimbra Portugal
Centro Medico Docente La Trinidad Caracas Venezuela
Children's Hospital University of Helsinki Helsinki Finland
Clinic of Allergy and Asthma Medical University Sofia Sofia Bulgaria
Clinic of Infectious Chest Diseases Dermatology and Allergology Vilnius University Vilnius Lithuania
Clínica de Alergia Asma y Pediatría Hospital Médica Sur Mexico City Mexico
Computing Science Department Umeå University Umeå Sweden ; Four Computing Oy Halikko Finland
Conseil Général de l'Economie Ministère de l'Economie de l'Industrie et du Numérique Paris France
Croatian Pulmonary Society Zagreb Croatia
David Hide Asthma and Allergy Research Centre Isle of Wight UK
Département de pédiatrie CHU de Grenoble Grenoble France
Department for Pediatric Pneumology and Immunology Charité Medical University Berlin Germany
Department of Allergy and Clinical Immunology Ajou University School of Medicine Suwon South Korea
Department of Allergy and Immunology Hospital Quirón Bizkaia Erandio Spain
Department of Clinical Epidemiology and Biostatistics McMaster University Hamilton ON Canada
Department of Clinical Immunology Wrocław Medical University Wrocław Poland
Department of Dermatology and Allergy Centre Odense University Hospital Odense Denmark
Department of Dermatology and Allergy Rheinische Friedrich Wilhelms University Bonn Bonn Germany
Department of Dermatology Medical University of Graz Graz Austria
Department of ENT Medical University of Graz Graz Austria
Department of Epidemiology Regional Health Service Lazio Region Rome Italy
Department of Geriatrics Getafe University Hospital Madrid Spain
Department of Health Social Services and Public Safety Belfast Northern Ireland UK
Department of Immunology Rheumatology and Allergy and HARC Medical University of Lodz Lodz Poland
Department of Medicine and Surgery University of Salerno Baronissi Italy
Department of Medicine Bon Secours Hospital Glasnevin Dublin Ireland
Department of Medicine Nova Southeastern University Davie FL USA
Department of Medicine University of Cape Town Cape Town South Africa
Department of Otolaryngology Nippon Medical School Tokyo Japan
Department of Otorhinolaryngology Academic Medical Centre Amsterdam The Netherlands
Department of Otorhinolaryngology Chiba University Hospital Chiba Japan
Department of Otorhinolaryngology HNO Klinik Universitätsklinikum Düsseldorf Düsseldorf Germany
Department of Paediatrics and Child Health University College Cork Cork Ireland
Department of Paediatrics Maputo Central Hospital Maputo Mozambique
Department of Paediatrics Oslo University Hospital Oslo Norway ; University of Oslo Oslo Norway
Department of Pediatric Imperial College London London UK
Department of Pediatrics Medical School Federal University of Minas Gerais Belo Horizonte Brazil
Department of Pediatrics Nippon Medical School Tokyo Japan
Department of Public Health and Infectious Diseases Sapienza University of Rome Rome Italy
Department of Public Health and Primary Care Leiden University Medical Center Leiden The Netherlands
Department of Pulmonary Diseases Cerrahpasa Faculty of Medicine Istanbul University Istanbul Turkey
Department of Pulmonary Medicine CHU Sart Tilman Liege Belgium
Department of Pulmonary Medicine Rashid Hospital Dubai UAE
Department of Pulmonology Celal Bayar University Manisa Turkey
Department of Research Olmsted Medical Center Rochester MN USA
Department of Respiratory Diseases Montpellier University Hospital Montpellier France
Department of Respiratory Diseases Odense University Hospital Odense Denmark
Department of Respiratory Medicine and Allergology University Hospital Lund Sweden
Department of Respiratory Medicine Ghent University Hospital Ghent Belgium
Department of Respiratory Medicine University of Bratislava Bratislava Slovakia
Department of Social Medicine Faculty of Medicine University of Crete Heraklion Crete Greece
DIBIMIS University of Palermo Palermo Italy
Division of Allergy and Clinical Immunology University of Salerno Salerno Italy
Division of Allergy Asthma and Clinical Immunology Emek Medical Center Afula Israel
Division of Allergy Immunology University of South Florida Tampa FL USA
Education for Health Warwick UK
EFA European Federation of Allergy and Airways Diseases Patients' Associations Brussels Belgium
ENT Department University Hospital of Kinshasa Kinshasa Congo
EPAR U707 INSERM Paris France ; EPAR UMR S UPMC Paris 6 Paris France
Eshelman School of Pharmacy University of North Carolina Chapel Hill NC USA
European Union Geriatric Medicine Society Helsinki Finland
Faculty of Medicine Autononous University of Madrid Madrid Spain
Faculty of the Department of Neurology University of Washington School of Medicine Seattle WA USA
Federico 2 University Hospital Naples Naples Italy
Finnish Lung Association Helsinki Finland
Geriatric Unit Department of Internal Medicine University of Palermo Palermo Italy
Gérontopôle de Toulouse 31059 Toulouse France
Global Allergy and Asthma Platform GAAPP Altgasse 8 10 1130 Vienna Austria
Guy's and St Thomas' NHS Trust Kings College London London UK
Hospital de Clinicas University of Parana Curitiba Brazil
Hospital de Niños Orlando Alassia Santa Fe Argentina
Hospital of the Hospitaller Brothers in Buda Budapest Hungary
Immunology and Allergy Division Clinical Hospital University of Chile Santiago Chile
Institute of Health Policy and Management IBMG Erasmus University Rotterdam The Netherlands
iQ4U Consultants Ltd London UK
Karl Landsteiner Institute for Clinical and Experimental Pneumology Hietzing Hospital Vienna Austria
Kronikgune Basque Region Spain
Libra Foundation Buenos Aires Argentina
LungenClinic Grosshansdorf Airway Research Center North German Center for Lung Research Kiel Germany
Medical Commission Montpellier University Hospital Montpellier France
Medical Faculty Vilnius University Vilnius Lithuania
Medical School University of Cyprus Nicosia Cyprus
Medicine Department IRCCS Azienda Ospedaliera Universitaria San Martino Genoa Italy
MedScript Ltd Dundalk County Louth Ireland
Montpellier Région Languedoc Roussillon France
Montpellier University Hospital Montpellier France
National Center for Disease Control and Public Health of Georgia Tbilisi Georgia
National eHealth Centre University Hospital Olomouc Olomouc Czech Republic
National Heart and Lung Institute Imperial College London London UK
National Hospital Organization Tokyo National Hospital Tokyo Japan
National Institute of Pneumology M Nasta Bucharest Romania
Neumología y Alergología Infantil Hospital La Fe Valencia Spain
NHS Foundation Trust University Hospitals of Southampton Southampton UK
Northern Health Alliance Newcastle UK
Otolaryngology and Head and Neck Surgery CHU Rangueil Larrey Toulouse France
Pediatric Allergy and Asthma Unit School of Medicine Hacettepe University Ankara Turkey
Pediatric Allergy and Immunology Unit Ain Shams University Cairo Egypt
Pediatric Department University of Verona Hospital Verona Italy
Peercode DV Amsterdam The Netherlands
Philippines Society of Allergy Asthma and Immunology Manila Philippines
Polibienestar Research Institute University of Valencia Valencia Spain
ProAR Nucleo de Excelencia em Asma Federal University of Bahia Salvador Brazil
Pulmonolory Research Institute FMBA Moscow Russia ; GARD Executive Committee Moscow Russia
Quebec Heart and Lung Institute Laval University Quebec City QC Canada
Queen's University Belfast Northern Ireland UK
Regional Ministry of Health of Andalusia Seville Spain
Respiratory Diseases Department Rangueil Larrey Hospital Toulouse France
Respiratory Medicine Department of Medical Sciences University of Ferrara Ferrara Italy
Royal Brompton Hospital NHS Imperial College London London UK
S Allergologia S Medicina Interna Hospital Vall d'Hebron Barcelona Spain
School of Medicine University CEU San Pablo Madrid Spain
School of Psychology Plymouth University Plymouth UK
Scientific Centre of Children's Health Under the Russian Academy of Medical Sciences Moscow Russia
Section of Allergology Department of Internal Medicine Erasmus MC Rotterdam The Netherlands
Section of Allergy and Immunology Saint Louis University School of Medicine Saint Louis MO USA
Service de Pneumo Allergologie Centre Hospitalo Universitaire de Béni Messous Algers Algeria
Service de Pneumo allergologie Hôpital Saint Joseph Paris France
Serviço de Imunoalergologia Hospital da Luz Lisbon Portugal
Skin and Allergy Hospital Helsinki University Hospital Helsinki Finland
Social Sciences University of Southampton Southampton UK
Sociedad Paraguaya de Alergia Asma e Inmunologıa Asunción Paraguay
Société de Pneumologie de Langue Française Espace francophone de Pneumologie Paris France
Sotiria Hospital Athens Greece
Swiss Institute of Allergy and Asthma Research University of Zurich Davos Switzerland
The Allergy and Asthma Institute Lahore Pakistan
The Queen's Medical Research Institute University of Edinburgh Edinburgh UK
The Royal National TNE Hospital University College London London UK
Tobacco Control Research Centre Iranian Anti Tobacco Association Tehran Iran
Transylvania University Brasov Brasov Romania
Ukrainian Medical Stomatological Academy Poltava Ukraine
Unit of Geriatric Immunoallergology University of Bari Medical School Bari Italy
Universidad Autónoma de Nuevo León San Nicolás de los Garza Mexico
Universidad Católica de Córdoba Córdoba Argentina
Universitätsmedizin der Johannes Gutenberg Universität Mainz Mainz Germany
University Clinic of Respiratory and Allergic Diseases Golnik Slovenia
University Medical Center Groningen University of Groningen Groningen The Netherlands
University of Medicine and Pharmacy Hochiminh City Vietnam
University of Medicine and Pharmacy Victor Babes Timisoara Romania
University of Southern Denmark Kolding Denmark
University Pneumology Unit AOU Molinette Hospital City of Health and Science of Torino Turin Italy
Upper Airways Research Laboratory ENT Department Ghent University Hospital Ghent Belgium
VIB Inflammation Research Center Ghent University Ghent Belgium
See more in PubMed
Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(5 Suppl):S147–S334. doi: 10.1067/mai.2001.118891. PubMed DOI
Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ. 1999;318(7183):593–596. doi: 10.1136/bmj.318.7183.593. PubMed DOI PMC
Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) Allergy. 2008;63(Suppl 86):8–160. doi: 10.1111/j.1398-9995.2007.01620.x. PubMed DOI
Brozek JL, Akl EA, Alonso-Coello P, Lang D, Jaeschke R, Williams JW, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy. 2009;64(5):669–677. doi: 10.1111/j.1398-9995.2009.01973.x. PubMed DOI
Brozek JL, Baena-Cagnani CE, Bonini S, Canonica GW, Rasi G, van Wijk RG, et al. Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update. Allergy. 2008;63(1):38–46. doi: 10.1111/j.1398-9995.2007.01560.x. PubMed DOI
Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3):466–476. doi: 10.1016/j.jaci.2010.06.047. PubMed DOI
Padjas A, Kehar R, Aleem S, Mejza F, Bousquet J, Schunemann HJ, et al. Methodological rigor and reporting of clinical practice guidelines in patients with allergic rhinitis: QuGAR study. J Allergy Clin Immunol. 2014;133(3):777–783.e4. doi: 10.1016/j.jaci.2013.08.029. PubMed DOI
Bousquet J, Schunemann HJ, Samolinski B, Demoly P, Baena-Cagnani CE, Bachert C, et al. Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol. 2012;130(5):1049–1062. doi: 10.1016/j.jaci.2012.07.053. PubMed DOI
Bousquet J, Schunemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW, et al. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy. 2015;70(11):1372–1392. doi: 10.1111/all.12686. PubMed DOI
Bousquet J, Michel J, Standberg T, Crooks G, Iakovidis I, Gomez M. The European Innovation Partnership on Active and Healthy Ageing: the European Geriatric Medicine introduces the EIP on AHA Column. Eur Geriatr Med. 2014;5(6):361–362. doi: 10.1016/j.eurger.2014.09.010. DOI
Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A, et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs) Eur Respir J. 2014;44(2):304–323. doi: 10.1183/09031936.00014614. PubMed DOI
Bousquet J, Barbara C, Bateman E, Bel E, Bewick M, Chavannes N, et al. AIRWAYS ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation. Eur Respir J. 2016;47(4):1028–1033. doi: 10.1183/13993003.01856-2015. PubMed DOI
Bousquet J, Anto JM, Berkouk K, Gergen P, Antunes JP, Auge P, et al. Developmental determinants in non-communicable chronic diseases and ageing. Thorax. 2015;70(6):595–597. doi: 10.1136/thoraxjnl-2014-206304. PubMed DOI PMC
Bousquet J, Barbara C, Bateman E, Bel E, Bewick M, Chavannes NH, et al. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation. Eur Respir J. 2016;47(4):1028–1033. doi: 10.1183/13993003.01856-2015. PubMed DOI
Bousquet J, Farrell J, Crooks G, Hellings P, Bel E, Bewick M, et al. Scaling up strategies of the Chronic Respiratory Disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3—Area 5) Clin Transl Allergy. 2016;6:29. doi: 10.1186/s13601-016-0116-9. PubMed DOI PMC
Bousquet J, Dahl R, Khaltaev N. Global alliance against chronic respiratory diseases. Allergy. 2007;62(3):216–223. doi: 10.1111/j.1398-9995.2007.01307.x. PubMed DOI
TRM Glossary. One-VA technical reference model v14.10. US Department of Veteran Affairs. http://www.vagov/trm/TRMGlossaryPageasp. 2014.
National Center for Complementary and Alternative Medicine (NCCAM). National Institutes of Health. Clinical practice guidelines. http://nccam.nih.gov/health/providers/clinicalpractice.htm. 2014.
Zander K. Historical development of outcomes-based care delivery. Crit Care Nurs Clin N Am. 1998;10(1):1–11. PubMed
Campbell H, Hotchkiss R, Bradshaw N, Porteous M. Integrated care pathways. BMJ. 1998;316(7125):133–137. doi: 10.1136/bmj.316.7125.133. PubMed DOI PMC
Overill S. A practical guide to care pathways. J Integr Care. 1998;2:93–98.
Integrated Care Pathways users in Scotland (ICPUS). A workbook for people starting to develop integrated care pathways. http://www.icpus.org.uk2007.
How to produce and evaluate an integrated care pathway (ICP): information for staff. Great Ormond Street Hospital for Children. www.gosh.nhs.uk. 2010.
ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergic rhinitis and its impact on asthma. Allergy. 2004;59(4):373–87. PubMed
Bousquet J, Neukirch F, Bousquet PJ, Gehano P, Klossek JM, Le Gal M, et al. Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol. 2006;117(1):158–162. doi: 10.1016/j.jaci.2005.09.047. PubMed DOI
Bousquet J, Annesi-Maesano I, Carat F, Leger D, Rugina M, Pribil C, et al. Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clin Exp Allergy. 2005;35(6):728–732. doi: 10.1111/j.1365-2222.2005.02274.x. PubMed DOI
Bousquet PJ, Devillier P, Tadmouri A, Mesbah K, Demoly P, Bousquet J. Clinical relevance of cluster analysis in phenotyping allergic rhinitis in a real-life study. Int Arch Allergy Immunol. 2015;166(3):231–240. doi: 10.1159/000381339. PubMed DOI
del Cuvillo A, Montoro J, Bartra J, Valero A, Ferrer M, Jauregui I, et al. Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients—the ADRIAL cohort study. Rhinology. 2010;48(2):201–205. PubMed
Jauregui I, Davila I, Sastre J, Bartra J, del Cuvillo A, Ferrer M, et al. Validation of ARIA (Allergic Rhinitis and its Impact on Asthma) classification in a pediatric population: the PEDRIAL study. Pediatr Allergy Immunol. 2011;22(4):388–392. doi: 10.1111/j.1399-3038.2010.01108.x. PubMed DOI
Cruz AA, Popov T, Pawankar R, Annesi-Maesano I, Fokkens W, Kemp J, et al. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy. 2007;62(Suppl 84):1–41. doi: 10.1111/j.1398-9995.2007.01551.x. PubMed DOI
Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy. 2007;62(Suppl 85):17–25. doi: 10.1111/j.1398-9995.2007.01549.x. PubMed DOI
Bousquet PJ, Demoly P, Devillier P, Mesbah K, Bousquet J. Impact of allergic rhinitis symptoms on quality of life in primary care. Int Arch Allergy Immunol. 2013;160(4):393–400. doi: 10.1159/000342991. PubMed DOI
Price D, Scadding G, Ryan D, Bachert C, Canonica GW, Mullol J, et al. The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey. Clin Transl Allergy. 2015;5:39. doi: 10.1186/s13601-015-0083-6. PubMed DOI PMC
Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol. 2007;120(5 Suppl):S94–138. PubMed
O’Byrne PM, Reddel HK, Eriksson G, Ostlund O, Peterson S, Sears MR, et al. Measuring asthma control: a comparison of three classification systems. Eur Respir J. 2010;36(2):269–276. doi: 10.1183/09031936.00124009. PubMed DOI
Reddel HK, Bateman ED, Becker A, Boulet LP, Cruz AA, Drazen JM, et al. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J. 2015;46(3):622–639. doi: 10.1183/13993003.00853-2015. PubMed DOI PMC
Bousquet J, Bourquin C, Augé P, Domy P, Bringer J, Camuzat T, et al. MACVIA-LR Reference Site of the European Innovation Partnership on Active and Healthy Ageing. Eur Geriatr Med. 2014;5(6):406–415. doi: 10.1016/j.eurger.2014.07.013. DOI
Bourret R, Bousquet J, Mercier J, Camuzat T, Bedbrook A, Demoly P, et al. MASK rhinitis, a single tool for integrated care pathways in allergic rhinitis. World Hosp Health Serv. 2015;51(3):36–39. PubMed
Bousquet J, Bachert C, Canonica GW, Mullol J, Van Cauwenberge P, Bindslev Jensen C, et al. Efficacy of desloratadine in intermittent allergic rhinitis: a GALEN study. Allergy. 2009;64:1516–1523. doi: 10.1111/j.1398-9995.2009.02115.x. PubMed DOI
Bousquet J, Bachert C, Canonica GW, Mullol J, Van Cauwenberge P, Jensen CB, et al. Efficacy of desloratadine in persistent allergic rhinitis—a GA(2)LEN study. Int Arch Allergy Immunol. 2010;153(4):395–402. doi: 10.1159/000316351. PubMed DOI
Morais-Almeida M, Santos N, Pereira AM, Branco-Ferreira M, Nunes C, Bousquet J, et al. Prevalence and classification of rhinitis in preschool children in Portugal: a nationwide study. Allergy. 2013;68(10):1278–1288. doi: 10.1111/all.12221. PubMed DOI
Morais-Almeida M, Pite H, Pereira AM, Todo-Bom A, Nunes C, Bousquet J, et al. Prevalence and classification of rhinitis in the elderly: a nationwide survey in Portugal. Allergy. 2013;68(9):1150–1157. PubMed
Klimek L, Bachert C, Mosges R, Munzel U, Price D, Virchow JC, et al. Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study. Allergy Asthma Proc. 2015;36(1):40–47. doi: 10.2500/aap.2015.36.3823. PubMed DOI
Ohta K, Bousquet PJ, Aizawa H, Akiyama K, Adachi M, Ichinose M, et al. Prevalence and impact of rhinitis in asthma. SACRA, a cross-sectional nation-wide study in Japan. Allergy. 2011;66(10):1287–1295. doi: 10.1111/j.1398-9995.2011.02676.x. PubMed DOI
Larenas-Linnemann D, Dinger H, Shah-Hosseini K, Michels A, Mosges R. Over diagnosis of persistent allergic rhinitis in perennial allergic rhinitis patients: a nationwide study in Mexico. Am J Rhinol Allergy. 2013;27(6):495–501. doi: 10.2500/ajra.2013.27.3957. PubMed DOI
Shao J, Cui YX, Zheng YF, Peng HF, Zheng ZL, Chen JY, et al. Efficacy and safety of sublingual immunotherapy in children aged 3–13 years with allergic rhinitis. Am J Rhinol Allergy. 2014;28(2):131–139. doi: 10.2500/ajra.2014.28.4006. PubMed DOI
Wei H, Zhang Y, Shi L, Zhang J, Xia Y, Zang J, et al. Higher dosage of HIFU treatment may lead to higher and longer efficacy for moderate to severe perennial allergic rhinitis. Int J Med Sci. 2013;10(13):1914–1920. doi: 10.7150/ijms.7117. PubMed DOI PMC
Tatar EC, Surenoglu UA, Saylam G, Isik E, Ozdek A, Korkmaz H. Is there any correlation between the results of skin-prick test and the severity of symptoms in allergic rhinitis? Am J Rhinol Allergy. 2012;26(1):e37–e39. doi: 10.2500/ajra.2012.26.3750. PubMed DOI PMC
Bousquet PJ, Bousquet-Rouanet L, Co Minh HB, Urbinelli R, Allaert FA, Demoly P. ARIA (Allergic Rhinitis and Its Impact on Asthma) classification of allergic rhinitis severity in clinical practice in France. Int Arch Allergy Immunol. 2007;143(3):163–169. doi: 10.1159/000099307. PubMed DOI
Rouve S, Didier A, Demoly P, Jankowsky R, Klossek JM, Anessi-Maesano I. Numeric score and visual analog scale in assessing seasonal allergic rhinitis severity. Rhinology. 2010;48(3):285–291. PubMed
Baiardini I, Braido F, Brandi S, Tarantini F, Bonini S, Bousquet PJ, et al. The impact of GINA suggested drugs for the treatment of asthma on health-related quality of life: a GA(2)LEN review. Allergy. 2008;63(8):1015–1030. doi: 10.1111/j.1398-9995.2008.01823.x. PubMed DOI
Yamamoto H, Yamada T, Sakashita M, Kubo S, Susuki D, Tokunaga T, et al. Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis. Allergy Asthma Proc. 2012;33(2):e17–e22. doi: 10.2500/aap.2012.33.3514. PubMed DOI
Bousquet PJ, Bachert C, Canonica GW, Casale TB, Mullol J, Klossek JM, et al. Uncontrolled allergic rhinitis during treatment and its impact on quality of life: a cluster randomized trial. J Allergy Clin Immunol. 2010;126(3):666–668.e1-5. doi: 10.1016/j.jaci.2010.06.034. PubMed DOI
Demoly P, Bousquet PJ, Mesbah K, Bousquet J, Devillier P. Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis. Clin Exp Allergy. 2013;43(8):881–888. doi: 10.1111/cea.12121. PubMed DOI
Bousquet PJ, Combescure C, Klossek JM, Daures JP, Bousquet J. Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis. J Allergy Clin Immunol. 2009;123(6):1349–1354. doi: 10.1016/j.jaci.2009.02.033. PubMed DOI
Vuurman EF, Vuurman LL, Lutgens I, Kremer B. Allergic rhinitis is a risk factor for traffic safety. Allergy. 2014;69(7):906–912. doi: 10.1111/all.12418. PubMed DOI
Hellgren J, Cervin A, Nordling S, Bergman A, Cardell LO. Allergic rhinitis and the common cold–high cost to society. Allergy. 2010;65(6):776–783. doi: 10.1111/j.1398-9995.2009.02269.x. PubMed DOI
Zuberbier T, Lotvall J, Simoens S, Subramanian SV, Church MK. Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review. Allergy. 2014;69(10):1275–1279. doi: 10.1111/all.12470. PubMed DOI
Lamb CE, Ratner PH, Johnson CE, Ambegaonkar AJ, Joshi AV, Day D, et al. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Curr Med Res Opin. 2006;22(6):1203–1210. doi: 10.1185/030079906X112552. PubMed DOI
Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol. 2007;120(2):381–387. doi: 10.1016/j.jaci.2007.03.034. PubMed DOI
Nolte H, Nepper-Christensen S, Backer V. Unawareness and undertreatment of asthma and allergic rhinitis in a general population. Respir Med. 2006;100(2):354–362. doi: 10.1016/j.rmed.2005.05.012. PubMed DOI
Bousquet J, Schunemann HJ, Hellings PW, Arnavielhe S, Bachert C, Bedbrook A, et al. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. J Allergy Clin Immunol. 2016;138(2):367–374.e2. doi:10.1016/j.jaci.2016.03.025. PubMed
Konig HH, Bernert S, Angermeyer MC, Matschinger H, Martinez M, Vilagut G, et al. Comparison of population health status in six european countries: results of a representative survey using the EQ-5D questionnaire. Med Care. 2009;47(2):255–261. doi: 10.1097/MLR.0b013e318184759e. PubMed DOI
Smith AF, Pitt AD, Rodruiguez AE, Alio JL, Marti N, Teus M, et al. The economic and quality of life impact of seasonal allergic conjunctivitis in a Spanish setting. Ophthalmic Epidemiol. 2005;12(4):233–242. doi: 10.1080/09286580590967781. PubMed DOI
Blanc PD, Trupin L, Eisner M, Earnest G, Katz PP, Israel L, et al. The work impact of asthma and rhinitis: findings from a population-based survey. J Clin Epidemiol. 2001;54(6):610–618. doi: 10.1016/S0895-4356(00)00349-8. PubMed DOI
Bousquet J, Bodez T, Gehano P, Klossek JM, Liard F, Neukirch F, et al. Implementation of guidelines for allergic rhinitis in specialist practices. A randomized pragmatic controlled trial. Int Arch Allergy Immunol. 2009;150(1):75–82. doi: 10.1159/000210383. PubMed DOI
Ohta K, Jean Bousquet P, Akiyama K, Adachi M, Ichinose M, Ebisawa M, et al. Visual analog scale as a predictor of GINA-defined asthma control. The SACRA study in Japan. J Asthma. 2013;50(5):514–521. doi: 10.3109/02770903.2013.786726. PubMed DOI
Hojo M, Ohta K, Iikura M, Mizutani T, Hirashima J, Sugiyama H. Clinical usefulness of a guideline-based screening tool for the diagnosis of allergic rhinitis in asthmatics: the Self Assessment of Allergic Rhinitis and Asthma questionnaire. Respirology. 2013;18(6):1016–1021. doi: 10.1111/resp.12116. PubMed DOI
Sullivan PW, Smith KL, Ghushchyan VH, Globe DR, Lin SL, Globe G. Asthma in USA: its impact on health-related quality of life. J Asthma. 2013;50(8):891–899. doi: 10.3109/02770903.2013.813035. PubMed DOI
van der Leeuw S, van der Molen T, Dekhuijzen PN, Fonseca JA, van Gemert FA, Gerth van Wijk R, et al. The minimal clinically important difference of the control of allergic rhinitis and asthma test (CARAT): cross-cultural validation and relation with pollen counts. NPJ Prim Care Respir Med. 2015;25:14107. PubMed PMC
Ciprandi G, Schiavetti I, Sorbello V, Ricciardolo FL. Perception of asthma symptoms as assessed on the visual analog scale in subjects with asthma: a real-life study. Respir Care. 2016;61(1):23–29. doi: 10.4187/respcare.04171. PubMed DOI
Belgrave DC, Buchan I, Bishop C, Lowe L, Simpson A, Custovic A. Trajectories of lung function during childhood. Am J Respir Crit Care Med. 2014;189(9):1101–1109. doi: 10.1164/rccm.201309-1700OC. PubMed DOI PMC
Bousquet J, Anto J, Sunyer J, Nieuwenhuijsen M, Vrijheid M, Keil T, et al. Pooling birth cohorts in allergy and asthma: European Union-funded initiatives—a MeDALL, CHICOS, ENRIECO, and GA(2)LEN joint paper. Int Arch Allergy Immunol. 2013;161(1):1–10. doi: 10.1159/000343018. PubMed DOI
Anto JM, Pinart M, Akdis M, Auffray C, Bachert C, Basagana X, et al. Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminar. J Allergy Clin Immunol. 2012;129(4):943–954.e4. doi: 10.1016/j.jaci.2012.01.047. PubMed DOI
Bousquet J, Anto J, Auffray C, Akdis M, Cambon-Thomsen A, Keil T, et al. MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy. 2011;66(5):596–604. doi: 10.1111/j.1398-9995.2010.02534.x. PubMed DOI
Bousquet J, Anto JM, Akdis M, Auffray C, Keil T, Momas I, et al. Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story. Allergy. 2016;71(11):1513–1525. doi: 10.1111/all.12880. PubMed DOI PMC
Ballardini N, Bergstrom A, Wahlgren CF, van Hage M, Hallner E, Kull I, et al. IgE antibodies in relation to prevalence and multimorbidity of eczema, asthma, and rhinitis from birth to adolescence. Allergy. 2016;71(3):342–349. doi: 10.1111/all.12798. PubMed DOI
Gabet S, Just J, Couderc R, Bousquet J, Seta N, Momas I. Early polysensitisation is associated to allergic multimorbidity in PARIS birth cohort infants. Pediatr Allergy Immunol. 2016;27(8):831–837. doi: 10.1111/pai.12622. PubMed DOI
Burte E, Bousquet J, Varraso R, Gormand F, Just J, Matran R, et al. Characterization of rhinitis according to the asthma status in adults using an unsupervised approach in the EGEA study. PLoS ONE. 2015;10(8):e0136191. doi: 10.1371/journal.pone.0136191. PubMed DOI PMC
Siroux V, Lupinek C, Resch Y, Curin M, Just J, Keil T, et al. Specific IgE and IgG measured by the MeDALL allergen-chip depend on allergen and route of exposure: the EGEA study. J Allergy Clin Immunol. 2016 PubMed
Just J, Elegbede CF, Deschildre A, Bousquet J, Moneret-Vautrin DA, Crepet A, et al. Three peanut allergic/sensitized phenotypes with gender difference. Clin Exp Allergy. 2016;46(12):1596–1604. doi: 10.1111/cea.12791. PubMed DOI
Bresciani M, Paradis L, Des Roches A, Vernhet H, Vachier I, Godard P, et al. Rhinosinusitis in severe asthma. J Allergy Clin Immunol. 2001;107(1):73–80. doi: 10.1067/mai.2001.111593. PubMed DOI
ten Brinke A, Grootendorst DC, Schmidt JT, De Bruine FT, van Buchem MA, Sterk PJ, et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol. 2002;109(4):621–626. doi: 10.1067/mai.2002.122458. PubMed DOI
ten Brinke A, Sterk PJ, Masclee AA, Spinhoven P, Schmidt JT, Zwinderman AH, et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J. 2005;26(5):812–818. doi: 10.1183/09031936.05.00037905. PubMed DOI
Wilson N, Bewick M, Dziworski W. Maintaining health despite chronic illness in the elderly: a multi-disciplinary study visit to the north of England region. Eur Geriatr Med. 2015;6(4):396–400. doi: 10.1016/j.eurger.2015.03.008. DOI
Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases
Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study
